Skip to main content
Back
Jul 8, 2026

Evolv Technologies $15 Million Stock Settlement Over Misleading Evolv Express Statements

Settlement Image

The Evolv Technologies $15 Million Stock Settlement Over Misleading Evolv Express Statements settlement offers $15M in total to eligible claimants who purchased or otherwise acquired evolv technologies holdings inc. publicly traded common stock between june 28, 2021 and oct. 25, 2024 (inclusive), or purchased common stock pursuant to evolv’s registration statement. The deadline to file is August 12, 2026. Proof of purchase is required.

Deadline
Last Day

Deadline: August 12, 2026

Total Settlement Amount
$15M

Total amount allocated for all claims

Individual Payout Range
TBD

Estimated amount per eligible claim

Proof of Purchase
Required

Claimants must submit the last four digits of their Social Security number or taxpayer identification number. They must also provide transaction and holding information, including: (1) number of Evolv common shares held as of the opening of trading on June 28, 2021; (2) trade dates and details for purchases, acquisitions, and sales from June 28, 2021 through Jan. 22, 2025 (including number of shares and total prices); and (3) number of shares held as of the close of trading on Jan. 22, 2025. Acceptable documentation includes brokerage confirmation slips and/or monthly brokerage account statements, or an authorized broker statement containing the transactional and holding details reflected in those slips or statements. Representatives submitting on behalf of others must provide proof of authority.

Settlement Summary

Evolv Technologies Holdings is a publicly traded company that makes cybersecurity products—most notably its “Evolv Express” platform. Between June 28, 2021 and Oct. 25, 2024, some investors claim the company’s public communications painted an overly positive picture of how effective Evolv Express was, how the company structured customer and channel-partner agreements (including use of extra “terms and conditions” beyond what some investors expected), and how it reported key financial metrics under generally accepted accounting principles. The core allegation was that these statements were materially false or misleading in ways that artificially boosted the company’s stock price, and that investors later suffered losses when corrective information came out and the shares declined. This settlement—$15 million in cash—stems from a securities class action asserting federal securities-law violations under the Exchange Act and the Securities Act. The lawsuit was filed as a way to aggregate many investors’ claims into one case, giving eligible shareholders who bought Evolv common stock during the class period a potential path to compensation without each investor litigating separately. While Evolv and certain officers and directors denied wrongdoing, settling is often used to avoid the time, expense, and unpredictability of trial; the significance for investors is that the court-approved resolution sets a framework for pro rata payments based on factors like purchase and sale dates, whether shares were held through specified “corrective disclosure” dates, and the estimated portion of price “inflation” attributed to the alleged misstatements. Broader implications include the continuing scrutiny facing public companies in the tech and cybersecurity sectors, where product claims, performance metrics, and contract practices can have outsized impact on valuation—and where disclosure obligations are tightly regulated by the SEC. Similar lawsuits commonly arise when investors allege that management’s statements about effectiveness, accounting, or business practices were not fully accurate or complete, leading to investor losses when the market learns the “truth.” In this settlement, eligibility depends on the share ticker history (including the earlier NHIC period and later EVLV trading), and the expected average recovery is relatively small per share after deductions, reflecting a pattern seen in many securities class actions under the Private Securities Litigation Reform Act framework and related SEC disclosure rules.

Entities Involved

Evolv Technologies Holdings Inc.
NewHold Investment Corp.
Evolv Express
Evolv Tech. Holdings Securities Litigation
Epiq
EvolvTechSecuritiesSettlement.com
Social Security Administration (referenced via SSN requirement)
ERISA (employee retirement plan context)
United States federal securities laws (Exchange Act and Securities Act referenced)

Related Topics

Evolv Technologies securities class action
Evolv Express false statements settlement
NHIC EVLV stock class action
Evolv Technologies $15 million settlement
securities fraud class action settlement
Exchange Act class action Evolv
Securities Act claim Evolv
investor claim deadline Aug. 12 2026
Epiq settlement administrator Evolv
Evolv tech settlement proof of claim
Evolv common stock lawsuit investors
artificial inflation stock price disclosure
failed to comply with GAAP Evolv settlement
channel partners terms and conditions lawsuit

Eligibility Requirements

  • Purchased or otherwise acquired Evolv Technologies Holdings Inc. publicly traded common stock between June 28, 2021 and Oct. 25, 2024 (inclusive), or purchased common stock pursuant to Evolv’s registration statement
  • Must have suffered damages as a result of the alleged securities law violations
  • Eligible shares include those trading as NHIC from June 28, 2021 through July 16, 2021 and as EVLV from July 19, 2021 through Oct. 25, 2024
  • Coverage includes NewHold Investment Corp. units (NHICU) purchased during June 28, 2021 through July 16, 2021, limited to the common stock component
  • Coverage includes Evolv securities converted into Evolv common stock as part of the July 2021 business combination (purchase price set at $10.50 per share for those shares)
  • To have a recognized loss on Exchange Act claims, shares must be purchased during the class period and held through the opening of trading on at least one corrective disclosure date (May 23, 2023; Oct. 12, 2023; Feb. 20, 2024; Mar. 13, 2024; or Oct. 25, 2024)
  • For payout eligibility, class members whose calculated payment would be less than $10 will not receive a distribution
  • Each separate legal entity must submit its own claim; one entity should include all accounts on a single claim form
  • Agents/representatives (e.g., executors, trustees) may file on behalf of others if they provide proof of authority

Stay Updated

Subscribe to our newsletter for the latest settlement updates and news.

Important Notice About Filing Claims

Submitting false information in a settlement claim is considered perjury and will result in your claim being rejected. Fraudulent claims harm legitimate class members and may result in legal consequences.

If you are unsure about your eligibility for this settlement, please visit the official settlement administrator’s website using the link provided above. Review the eligibility criteria carefully before submitting a claim.

Class Action Champion is an independent information resource and is not affiliated with any settlement administrator, law firm, or court. We provide settlement information as a service to help connect eligible class members with legitimate settlements.

Related Settlements

Anne Arundel Dermatology Data Breach Settlement $2.4 Million for Patient Info Security Claims

Anne Arundel Dermatology P.A. agreed to pay a $2.4 million settlement to resolve allegations that a data breach exposed patients’ personal and health information. The incident occurred between Feb. 14, 2025, and May 13, 2025. Eligible class members are people in the U.S. who provided or whose information the clinic collected, received, or possessed on or before Dec. 9, 2025.

Travelers PIP Settlement for New Jersey Claims Up to 70 or More for Deductible Reductions

A class action settlement totaling at least the net settlement fund (with attorneys’ fees up to $275,000 and service awards of $7,500) resolves allegations that Travelers and St. Paul improperly reduced New Jersey PIP coverage limits by counting deductibles and copayments, causing some insureds to receive less than the PIP benefits available. Eligible policyholders (and certain heirs/representatives) who received final PIP payments between April 14, 2017 and April 1, 2023 that were within $3,000 of their policy limit—but not the full limit—may receive an automatic $70 and possibly additional compensation.

MUBI $1.6 Million Settlement for California Auto-Renewal Without Notice

California subscribers of the MUBI streaming service may be eligible for a $1.6 million class action settlement over alleged auto-renewal charges without adequate notice or proper consent. The claims cover sign-ups beginning April 1, 2021 and auto-renewals occurring through May 31, 2025, as described in Cesar Cejudo v. MUBI, Inc. To be eligible, claimants must have been California residents whose subscription renewed at least once and who did not receive a full refund of renewal charges.

MetLife $1.2 Million Settlement for Underinsured Motorist Coverage Offsets in New Mexico

Metropolitan Direct Property and Casualty Insurance Co. (MetLife) agreed to pay $1.2 million to settle claims that it misrepresented or failed to disclose underinsured motorist (UM/UIM) coverage limits and used improper offsets. The issue relates to New Mexico auto insurance activity between Oct. 1, 2010, and Jan. 31, 2022. Eligible class members include qualifying policyholders who had UM/UIM claim offsets by at-fault payments or who purchased UM/UIM coverage in that period.